Metraipolis › archive › dc_406804da1bce
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy — Europe PMC PMID:41471300
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41471300
- DOI
- 10.3390/ph18121811
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:31:51.773Z
- SHA-256 of the archived text
df11d47ed78def6054b54e1af0a3b1f8e90213d6c297c0b8190db8ac5489f4f6- Stable URL of this page
https://metraipolis.com/documento/dc_406804da1bce
How to cite
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy — Europe PMC PMID:41471300 — Europe PMC (en), https://europepmc.org/article/MED/41471300 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_406804da1bce (Metraipolis archive dc_406804da1bce, sha256 df11d47ed78def6054b54e1af0a3b1f8e90213d6c297c0b8190db8ac5489f4f6)
BibTeX
@misc{dc406804da1bce,
title = {Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy — Europe PMC PMID:41471300},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41471300},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_406804da1bce; sha256 df11d47ed78def6054b54e1af0a3b1f8e90213d6c297c0b8190db8ac5489f4f6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471300. Agents can read the archived copy with the MCP tool read_document.